Navigation Links
Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
Date:8/20/2007

ystemic formulation of humanized form of Sphingomab(TM)) is an antibody against S1P that holds promise for the treatment of cancer and other diseases. A second product candidate, iSONEP(TM) (the ocular formulation of humanized Sphingomab), has demonstrated superior results in various preclinical AMD models. Lpath's third product candidate, Lpathomab(TM), is an antibody against LPA, a key bioactive lipid that has been long recognized as a valid disease target. The company's unique ability to generate novel antibodies against bioactive lipids is based on its ImmuneY2(TM) drug-discovery engine, which the company is using to add to its pipeline. For more information, visit http://www.Lpath.com

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that required clinical trials will be successful, necessary regulatory approvals will be obtained, or the proposed treatments will prove to be safe or effective. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, our limited experience in the development of therapeutic drugs, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on research grants, current and future competition, and other risks described from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances aris
'/>"/>

SOURCE Lpath, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Lpath Demonstrates First-in-Class AMD Results With Its Lead Drug Candidate, Sphingomab
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
7. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
8. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
9. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 ApolloDx™ today announced it ... during a special event at the company,s office in ... September 5, 2014. The event, which will start at ... website, www.apollodx.com .    "We believe ... Jared Bauer , Co-Founder and Managing Partner of ...
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces that ... its catalogue: The Market for Medical ... The European, Middle Eastern and African markets ... As part of its coverage, this study: The ... the EMEA medical device markets and estimates markets ...
(Date:8/20/2014)... -- Reportlinker.com announces that a new market research ... Global Patient Scales Industry ... worldwide markets for Patient Scales in US$ Thousand ... & Baby Scales, Chair Scales, and Under Bed ... the US, Canada, Japan, Europe, Asia-Pacific, Latin America, ...
Breaking Medicine Technology:The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19
... July 12, 2011 Imagenetix, Inc. (OTCBB: IAGX) issued today a ... 31, 2011 and its focus for the future. ... fiscal year ended March 31, 2011 and as we commence the ... and summarize our strategic focus for the future.   ...
... July 12, 2011 Roche (SIX: RO, ROG; ... CALP ) today announced a co-marketing ... protocols for the NimbleGen SeqCap EZ Library solution-based ... collaboration aims to simplify high throughput targeted resequencing ...
Cached Medicine Technology:Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 2Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 3Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 2Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 3
(Date:8/20/2014)... is now, Free content, The time to deploy ... being published early online today in Annals ... School of Public Health write that the relentless epidemiologic ... represent a public health crisis that shows no signs ... been developed in the last decade, yet the sporadic ...
(Date:8/20/2014)... By Dennis Thompson ... -- Regular exercise may help older women avoid a condition ... Physically active postmenopausal women had a 10 percent lower ... more sedentary, researchers report in the Aug. 20 issue of ... Active women enjoyed this protection against the heart rhythm disorder ...
(Date:8/20/2014)... persistent and deadliest infectious diseases in the world, killing ... who study tuberculosis have long debated its origins. New ... Africa to seals and sea lions that brought the ... people there before Europeans landed on the continent. , ... Source of New World Human Tuberculosis," was published in ...
(Date:8/20/2014)... Researchers have found a novel approach to treating cancer ... August edition of Science Translational Medicine shows ... signals sent by nerves that are linked to cancer ... use of Botox made the treatment cheap, safe and ... on mice, and will soon start testing on humans. ...
(Date:8/20/2014)... Quincy Bioscience, a Wisconsin-based biotech company, has been ... fastest growing private companies in the nation , for ... Bioscience is honored again to be grouped with the ... Bioscience is manufacturer of Prevagen brand supplements, which contain ... in jellyfish and clinically shown to improve memory. Sales ...
Breaking Medicine News(10 mins):Health News:News from Annals of Internal Medicine 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:Treating gastric cancer -- with Botox 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2
... proposed to initiate mass-production of a live bird flu vaccine ... the start of next year // in China. This ... a vaccine for humans. ,More than 1-billion ... the year-end. This would be a supplement to the already ...
... waves had left over 25,000 people dead and many more ... Indian Ocean countries. // One in five Thai ... that forever changed the physical, social and psychological landscape of ... interviews, an average of 20 percent of Thai tsunami survivors ...
... will make women more empowered. They have now developed ... completely.,The pill developed by New Jersey-based Wyeth and called ... and the inconvenience of periods. ,Critics have warned ... and breast cancer. They said continuous exposure to hormones ...
... give a false picture about coma survival and recovery rates ... felt // by coma patients and found that the ... not true as the study show that only 8% of ... with 50% upwards in real life. ,The recovery ...
... by researchers at Washington University School of Medicine in St. ... rapidly after treatment and are not as depressed as some ... of this study appear in the December issue of Supportive ... underwent radiation therapy at Siteman Cancer Center at Washington University ...
... picture of coma patients' survival and recovery, with potentially important ... storylines containing coma patients over 10 years, researchers found that ... coma than in real life. And they were also much ... of soap land patients died during coma, compared with over ...
Cached Medicine News:
... is ideal for all liquid handling applications ... operating buttons, and various dispensing techniques such ... make this a lab favorite. It intuitively ... pipette without any adverse effects on the ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
Medicine Products: